128 related articles for article (PubMed ID: 26388246)
1. Preoperative TSH and thyroglobulin levels: would it predict thyroid cancer?
Al-Bader A; Zawawi F; Singer Z; Mlynarek A; Hier M; Tamilia M; Payne R
Otolaryngol Pol; 2015; 69(3):21-5. PubMed ID: 26388246
[TBL] [Abstract][Full Text] [Related]
2. Which is the best predictor of thyroid cancer: thyrotropin, thyroglobulin or their ratio?
Yazici P; Mihmanli M; Bozkurt E; Ozturk FY; Uludag M
Hormones (Athens); 2016 Apr; 15(2):256-263. PubMed ID: 27376428
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum thyroglobulin as an adjunct to fine-needle aspiration in predicting well-differentiated thyroid cancer.
Sands NB; Karls S; Rivera J; Tamilia M; Hier MP; Black MJ; Gologan O; Payne RJ
J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):669-73. PubMed ID: 21144363
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio in differentiated thyroid cancer.
Lin Y; Li T; Liang J; Li X; Qiu L; Wang S; Chen Y; Kang Z; Li F
Clin Nucl Med; 2011 Dec; 36(12):1102-5. PubMed ID: 22064080
[TBL] [Abstract][Full Text] [Related]
6. Can preoperative serum thyroglobulin levels predict the risk of malignancy? Results from prospective analysis of biochemical predictors of malignancy in thyroid nodules.
Hulikal N; Re A; Banoth M; Chowhan AK; Yutla M; Sachan A
Acta Otorhinolaryngol Ital; 2020 Feb; 40(1):33-37. PubMed ID: 32275647
[TBL] [Abstract][Full Text] [Related]
7. Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.
Zhao T; Liang J; Guo Z; Li J; Lin Y
Endocrine; 2016 Jul; 53(1):166-73. PubMed ID: 26782372
[TBL] [Abstract][Full Text] [Related]
8. Variability of Serum Thyroglobulin Levels in Post- Thyroidectomy Patients with Well-Differentiated Thyroid Cancer: the ATA Guidelines.
Silva F; Martin RJ; Figueroa J; Rincón F; Román D
P R Health Sci J; 2016 Sep; 35(3):142-6. PubMed ID: 27623139
[TBL] [Abstract][Full Text] [Related]
9. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
[TBL] [Abstract][Full Text] [Related]
10. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
[TBL] [Abstract][Full Text] [Related]
11. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
12. Effect of TSH stimulation on serum thyroglobulin in metastatic thyroid cancer.
Lo Gerfo P; Colacchio TA; Colacchio DA; Feind CR
J Surg Oncol; 1980; 14(3):195-200. PubMed ID: 7392641
[TBL] [Abstract][Full Text] [Related]
13. In search of an unstimulated thyroglobulin baseline value in low-risk papillary thyroid carcinoma patients not receiving radioactive iodine ablation.
Angell TE; Spencer CA; Rubino BD; Nicoloff JT; LoPresti JS
Thyroid; 2014 Jul; 24(7):1127-33. PubMed ID: 24697314
[TBL] [Abstract][Full Text] [Related]
14. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.
Kamel N; Güllü S; Dağci Ilgin S; Corapçioğlu D; Tonyukuk Cesur V; Uysal AR; Başkal N; Erdoğan G
Thyroid; 1999 Dec; 9(12):1245-8. PubMed ID: 10646665
[TBL] [Abstract][Full Text] [Related]
15. Serum thyroglobulin improves the sensitivity of the McGill Thyroid Nodule Score for well-differentiated thyroid cancer.
Scheffler P; Forest VI; Leboeuf R; Florea AV; Tamilia M; Sands NB; Hier MP; Mlynarek AM; Payne RJ
Thyroid; 2014 May; 24(5):852-7. PubMed ID: 24341425
[TBL] [Abstract][Full Text] [Related]
16. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
Pacini F; Molinaro E; Lippi F; Castagna MG; Agate L; Ceccarelli C; Taddei D; Elisei R; Capezzone M; Pinchera A
J Clin Endocrinol Metab; 2001 Dec; 86(12):5686-90. PubMed ID: 11739420
[TBL] [Abstract][Full Text] [Related]
17. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
Zafón C; Obiols G; Mesa J
Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
[TBL] [Abstract][Full Text] [Related]
18. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.
Kim TY; Kim WB; Kim ES; Ryu JS; Yeo JS; Kim SC; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2005 Mar; 90(3):1440-5. PubMed ID: 15613412
[TBL] [Abstract][Full Text] [Related]
19. Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burden.
Oltmann SC; Leverson G; Lin SH; Schneider DF; Chen H; Sippel RS
J Surg Res; 2014 Mar; 187(1):1-5. PubMed ID: 24411304
[TBL] [Abstract][Full Text] [Related]
20. A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later.
Kloos RT; Mazzaferri EL
J Clin Endocrinol Metab; 2005 Sep; 90(9):5047-57. PubMed ID: 15972576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
